GSK — GLAXOSMITHKLINE PLC SPONSORED ADR

Ownership history in MATHER GROUP, LLC.  ·  7 quarters on record

This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in GLAXOSMITHKLINE PLC SPONSORED ADR (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2011 Q2)
Avg. % of fund
0.0%
First filed
2011 Q2
Last filed
2025 Q3
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 755 +330 +77.6% 0.00% $33K $42.44
2025 Q1 ADDED 425 +133 +45.5% 0.00% $16K $37.25
2024 Q4 REDUCED 292 -436 -59.9% 0.00% $10K $32.17
2024 Q3 ADDED 728 +185 +34.1% 0.00% $30K $38.44
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% Clean Yield Group 3Y 7Y 2.2% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05%
← Back to MATHER GROUP, LLC. Holdings